Literature DB >> 25637348

The Intrahepatic T Cell Compartment Does Not Normalize Years After Therapy-Induced Hepatitis C Virus Eradication.

Michelle Spaan1, Mark A A Claassen2, Jun Hou1, Harry L A Janssen3, Robert J de Knegt1, Andre Boonstra1.   

Abstract

Little is known about the immune status in liver and blood of patients with chronic hepatitis C virus (HCV) infection long after therapy-induced viral clearance. In this study, we demonstrate that, 4 years after clearance, regulation of HCV-specific immunity in blood by regulatory T cells (Tregs) and the immunosuppressive cytokines interleukin 10 and transforming growth factor β is still ongoing. Importantly, analysis of liver specimens collected 4 years after HCV clearance shows that intrahepatic Tregs are still present in all patients, suggesting that liver T cells remain regulated. Identifying mechanisms that regulate HCV-specific memory T-cell responses after clearance is highly relevant for the development of protective vaccines, especially in patients at high risk of reinfection.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  IL-10; TGF-β; Treg; gene expression; intrahepatic

Mesh:

Substances:

Year:  2015        PMID: 25637348     DOI: 10.1093/infdis/jiv059

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Hepatitis C virus treatment with direct-acting antivirals induces rapid changes in the hepatic proteome.

Authors:  Lauren E Ball; Bernice Agana; Susana Comte-Walters; Don C Rockey; Henry Masur; Shyam Kottilil; Eric G Meissner
Journal:  J Viral Hepat       Date:  2021-08-19       Impact factor: 3.728

Review 2.  Reversing immune dysfunction and liver damage after direct-acting antiviral treatment for hepatitis C.

Authors:  Sabrina Mazouz; Maude Boisvert; Naglaa H Shoukry; Daniel Lamarre
Journal:  Can Liver J       Date:  2018-07-17

3.  Insights Into the Pathophysiology of Liver Disease in HCV/HIV: Does it End With HCV Cure?

Authors:  Andre J Jeyarajan; Raymond T Chung
Journal:  J Infect Dis       Date:  2020-11-27       Impact factor: 5.226

4.  Characterization of changes in intrahepatic immune cell populations during HCV treatment with sofosbuvir and ribavirin.

Authors:  Cody Orr; Johannes Aartun; Henry Masur; Shyam Kottilil; Eric G Meissner
Journal:  J Viral Hepat       Date:  2018-12-03       Impact factor: 3.728

5.  Association between a progesterone receptor mutation and hepatitis E sero-positivity in liver transplant recipients.

Authors:  Jose D Debes; Zwier M A Groothuismink; Robert A de Man; Andre Boonstra
Journal:  J Med Virol       Date:  2020-06-30       Impact factor: 2.327

6.  Mucosal-associated invariant T-cell frequency and function in blood and liver of HCV mono- and HCV/HIV co-infected patients with advanced fibrosis.

Authors:  Boris J B Beudeker; Gertine W van Oord; Joop E Arends; Julian Schulze Zur Wiesch; Marieke S van der Heide; Robert J de Knegt; Annelies Verbon; Andre Boonstra; Mark A A Claassen
Journal:  Liver Int       Date:  2017-09-16       Impact factor: 5.828

7.  Observed Changes in Natural Killer and T cell Phenotypes with Evaluation of Immune Outcome in a Longitudinal Cohort Following Sofosbuvir-Based Therapy for Chronic Hepatitis C Infection.

Authors:  Timothy J Stevenson; Youssef Barbour; Brian J McMahon; Lisa Townshend-Bulson; Annette M Hewitt; Hannah G F Espera; Chriss Homan; Peter Holck; Sarah V Luna; Cindy Knall; Brenna C Simons
Journal:  Open Forum Infect Dis       Date:  2019-05-17       Impact factor: 3.835

Review 8.  Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment.

Authors:  Srikanta Dash; Yucel Aydin; Kyle E Widmer; Leela Nayak
Journal:  J Hepatocell Carcinoma       Date:  2020-04-15

9.  Rapid changes in peripheral lymphocyte concentrations during interferon-free treatment of chronic hepatitis C virus infection.

Authors:  Eric G Meissner; Anita Kohli; Jeanette Higgins; Yu-Jin Lee; Olga Prokunina; David Wu; Cody Orr; Henry Masur; Shyam Kottilil
Journal:  Hepatol Commun       Date:  2017-07-24

10.  Gene expression profiling of human tissue-resident immune cells: Comparing blood and liver.

Authors:  Lauke L Boeijen; Gertine W van Oord; Jun Hou; Marieke van der Heide-Mulder; Anuj Gaggar; Li Li; Simon P Fletcher; Robert J de Knegt; André Boonstra
Journal:  J Leukoc Biol       Date:  2018-11-27       Impact factor: 4.962

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.